Pancreatic cancer (PanC) is among the deadliest malignancies world-wide and frontline
Pancreatic cancer (PanC) is among the deadliest malignancies world-wide and frontline treatment with gemcitabine becomes eventually inadequate due to raising PanC resistance, suggesting extra approaches are had a need to manage PanC. NANOG and OCT4, and CSC marker Compact disc44. Immunohistochemical evaluation of MiaPaCa2 xenografts from BMJ treated pets also showed a substantial reduction in … [Read more…]